1Yamada K, Furusawa S, Saito K, et al. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study. Leukemia, 1995, 9:10-14.
2Park L S, Waldron P E, Friend D, et al. Interleukin-3, GM-CSF and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness. Blood, 1989, 74:56-65.
3Reuter C, Schleyer E, Rolf C, et al. Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia(AML)blasts. Leukemia, 1997, 11:561-571.
4Buechner T, Hiddemann W. Treatment strategies in acute myeloid leukemia(AML): a first line chemotherapy. Blut, 1990. 60-67.
6YAMADA K, FURUSAWA S, SAITO K, etal. Concurrent use of granulocyte colony- stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia:a pilot study[J]. Leukemia, 1995, 9(1 ): 10-14.
7AMUGULENG B, HIROSHI K, MITSNO H, et al. Priming with G-CSF effectively enhances low- dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells[J]. Exp Hematol, 1999, 27(2):259-265.
8KATAGIRI T, MIYAZAWA K, NISHIMAKI J, etal. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro[J]. Leuk Lymphoma, 2000, 39(1 -2):1 73-184.
9HAROUSEAN J L, WU D P. The use of GM-CSF and G-CSF in the treatment of acute leukemia[J]. Leuk Lymphoma, 1995, 1 8(5-6):405-412.
10REUTER C, SCHLEYER E, ROLF C, et al. Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia(AML)blasts[J]. Leukemia, 1997, 11(4):561-571.
